BNP Paribas Initiates Coverage on Procter & Gamble (NYSE:PG)

Research analysts at BNP Paribas assumed coverage on shares of Procter & Gamble (NYSE:PGGet Free Report) in a research report issued on Monday, Marketbeat Ratings reports. The brokerage set an “outperform” rating and a $187.00 price target on the stock. BNP Paribas’ target price indicates a potential upside of 12.04% from the stock’s current price.

A number of other equities analysts have also weighed in on PG. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Procter & Gamble from $172.00 to $171.00 and set a “buy” rating for the company in a report on Monday, April 22nd. Truist Financial upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $160.00 to $175.00 in a report on Monday, March 11th. StockNews.com lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating in a report on Monday, June 17th. Argus boosted their price objective on shares of Procter & Gamble from $180.00 to $185.00 and gave the stock a “buy” rating in a report on Thursday, April 25th. Finally, The Goldman Sachs Group initiated coverage on shares of Procter & Gamble in a report on Friday, March 1st. They issued a “neutral” rating and a $168.00 price objective for the company. Six investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $170.72.

View Our Latest Stock Analysis on PG

Procter & Gamble Price Performance

PG stock opened at $166.90 on Monday. The firm has a 50 day moving average price of $165.07 and a 200-day moving average price of $158.47. Procter & Gamble has a 52-week low of $141.45 and a 52-week high of $169.41. The firm has a market capitalization of $393.91 billion, a price-to-earnings ratio of 27.27, a PEG ratio of 3.42 and a beta of 0.42. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.48 and a current ratio of 0.69.

Procter & Gamble (NYSE:PGGet Free Report) last released its earnings results on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.10. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The firm had revenue of $20.20 billion during the quarter, compared to analyst estimates of $20.43 billion. During the same period last year, the business earned $1.37 earnings per share. The business’s revenue was up .6% on a year-over-year basis. Equities research analysts forecast that Procter & Gamble will post 6.55 EPS for the current fiscal year.

Insider Activity

In related news, CEO R. Alexandra Keith sold 855 shares of the company’s stock in a transaction on Monday, April 22nd. The shares were sold at an average price of $158.50, for a total value of $135,517.50. Following the completion of the transaction, the chief executive officer now owns 4,004 shares of the company’s stock, valued at approximately $634,634. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, CEO R. Alexandra Keith sold 855 shares of the company’s stock in a transaction on Monday, April 22nd. The shares were sold at an average price of $158.50, for a total value of $135,517.50. Following the completion of the transaction, the chief executive officer now owns 4,004 shares of the company’s stock, valued at approximately $634,634. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Sundar G. Raman sold 31,924 shares of the company’s stock in a transaction on Monday, May 20th. The stock was sold at an average price of $166.95, for a total transaction of $5,329,711.80. Following the completion of the transaction, the chief executive officer now directly owns 19,042 shares of the company’s stock, valued at approximately $3,179,061.90. The disclosure for this sale can be found here. Insiders sold a total of 154,544 shares of company stock valued at $25,413,051 in the last 90 days. Company insiders own 0.17% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the company. Lazari Capital Management Inc. lifted its stake in Procter & Gamble by 2.7% in the 1st quarter. Lazari Capital Management Inc. now owns 2,681 shares of the company’s stock worth $435,000 after purchasing an additional 70 shares in the last quarter. Cape Investment Advisory Inc. lifted its stake in Procter & Gamble by 44.8% in the 1st quarter. Cape Investment Advisory Inc. now owns 4,651 shares of the company’s stock worth $755,000 after purchasing an additional 1,438 shares in the last quarter. SRN Advisors LLC lifted its stake in Procter & Gamble by 4.5% in the 1st quarter. SRN Advisors LLC now owns 6,197 shares of the company’s stock worth $1,005,000 after purchasing an additional 268 shares in the last quarter. NBW Capital LLC purchased a new stake in Procter & Gamble in the 1st quarter worth $273,000. Finally, Keynote Financial Services LLC purchased a new stake in Procter & Gamble in the 1st quarter worth $2,250,000. Institutional investors own 65.77% of the company’s stock.

About Procter & Gamble

(Get Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Recommended Stories

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.